{
    "eid": "2-s2.0-85151961205",
    "title": "The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5",
    "cover-date": "2023-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "booster dose",
        "immunogenicity",
        "mRNA vaccine",
        "Omicron",
        "safety",
        "severe acute respiratory virus 2 (SARS-CoV-2)"
    ],
    "authors": [
        "Sitthichai Kanokudom",
        "Jira Chansaenroj",
        "Nungruthai Suntronwong",
        "Suvichada Assawakosri",
        "Ritthideach Yorsaeng",
        "Pornjarim Nilyanimit",
        "Ratchadawan Aeemjinda",
        "Nongkanok Khanarat",
        "Preeyaporn Vichaiwattana",
        "Sirapa Klinfueng",
        "Thanunrat Thongmee",
        "Donchida Srimuan",
        "Thaksaporn Thatsanathorn",
        "Natthinee Sudhinaraset",
        "Nasamon Wanlapakorn",
        "Sittisak Honsawek",
        "Yong Poovorawan"
    ],
    "citedby-count": 2,
    "ref-count": 28,
    "ref-list": [
        "Evolution of the SARS-CoV-2 Omicron variants BA.1 to BA.5: Implications for immune escape and transmission",
        "Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa",
        "Fourth dose of BNT162b2 mRNA COVID-19 vaccine in a nationwide setting",
        "Effectiveness of third vaccine dose for Coronavirus disease 2019 during the Omicron variant pandemic: A prospective observational study in Japan",
        "Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study",
        "Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants",
        "Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster",
        "Vaccine effectiveness of primary series and booster doses against COVID-19 associated hospital admissions in the United States: Living test negative design study",
        "Persistence of immunity against Omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination",
        "Neutralizing activities against the Omicron variant after a heterologous booster in healthy adults receiving two doses of CoronaVac vaccination",
        "Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine",
        "Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax(TM)) after homologous and heterologous two-dose regimens",
        "Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination",
        "Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges",
        "Protection by a fourth dose of BNT162b2 against Omicron in Israel",
        "Efficacy of a fourth dose of COVID-19 mRNA vaccine against Omicron",
        "Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden",
        "Israeli-Hospitals 4th Vaccine Working Group.; Association of receiving a fourth dose of the BNT162b vaccine with SARS-CoV-2 infection among health care workers in Israel",
        "Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: A test-negative, case-control study",
        "Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine",
        "An mRNA vaccine against SARS-CoV-2\u2014Preliminary report",
        "Immunogenicity of the BNT162b2 COVID-19 vaccine as a third dose (booster) following two doses of different primary series regimens in Thailand",
        "Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCoV-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial",
        "Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): A multicentre, blinded, phase 2, randomised trial",
        "Strong correlations between the binding antibodies against wild-type and neutralizing antibodies against Omicron BA.1 and BA.2 variants of SARS-CoV-2 in individuals following booster (third-dose) vaccination"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "101823394",
            "affilname": "Royal Society of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101823394",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Clinical Virology",
        "Group Aunt Thongkum Foundation",
        "Second Century Fund",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "National Research Council of Thailand",
        "Health Systems Research Institute"
    ]
}